TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling.
Ma L, She C, Shi Q, Yin Q, Ji X, Wang Y, Fan Y, Kong X, Li P, Sun Z, Zhang X, Zhang Z, Wang J, Wang T, Xu Y, Li W.
Ma L, et al. Among authors: wang j, wang y, wang t.
Cancer Biol Med. 2019 Aug;16(3):606-617. doi: 10.20892/j.issn.2095-3941.2019.0011.
Cancer Biol Med. 2019.
PMID: 31565489
Free PMC article.